Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells. by Diniz, Ivana MA et al.
UCLA
UCLA Previously Published Works
Title
Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived 
mesenchymal stem cells.
Permalink
https://escholarship.org/uc/item/7jd30725
Journal
Journal of materials science. Materials in medicine, 26(3)
ISSN
0957-4530
Authors
Diniz, Ivana MA
Chen, Chider
Xu, Xingtian
et al.
Publication Date
2015-03-15
DOI
10.1007/s10856-015-5493-4
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
TISSUE ENGINEERING CONSTRUCTS AND CELL SUBSTRATES
Pluronic F-127 hydrogel as a promising scaffold for encapsulation
of dental-derived mesenchymal stem cells
Ivana M. A. Diniz1,2 • Chider Chen1 • Xingtian Xu1 • Sahar Ansari1,3 •
Homayoun H. Zadeh3 • Ma´rcia M. Marques2 • Songtao Shi1 • Alireza Moshaverinia1
Received: 3 September 2014 / Accepted: 9 February 2015 / Published online: 15 March 2015
 Springer Science+Business Media New York 2015
Abstract Dental-derived mesenchymal stem cells
(MSCs) provide an advantageous therapeutic option for
tissue engineering due to their high accessibility and
bioavailability. However, delivering MSCs to defect sites
while maintaining a high MSC survival rate is still a cri-
tical challenge in MSC-mediated tissue regeneration. Here,
we tested the osteogenic and adipogenic differentiation
capacity of dental pulp stem cells (DPSCs) in a ther-
moreversible Pluronic F127 hydrogel scaffold encapsula-
tion system in vitro. DPSCs were encapsulated in
Pluronic F-127 hydrogel and stem cell viability, prolif-
eration and differentiation into adipogenic and osteogenic
tissues were evaluated. The degradation profile and swel-
ling kinetics of the hydrogel were also analyzed. Our re-
sults confirmed that Pluronic F-127 is a promising and non-
toxic scaffold for encapsulation of DPSCs as well as con-
trol human bone marrow MSCs (hBMMSCs), yielding high
stem cell viability and proliferation. Moreover, after
2 weeks of differentiation in vitro, DPSCs as well as
hBMMSCs exhibited high levels of mRNA expression for
osteogenic and adipogenic gene markers via PCR analysis.
Our histochemical staining further confirmed the ability of
Pluronic F-127 to direct the differentiation of these stem
cells into osteogenic and adipogenic tissues. Furthermore,
our results revealed that Pluronic F-127 has a dense tubular
and reticular network morphology, which contributes to its
high permeability and solubility, consistent with its high
degradability in the tested conditions. Altogether, our
findings demonstrate that Pluronic F-127 is a promising
scaffold for encapsulation of DPSCs and can be considered
for cell delivery purposes in tissue engineering.
1 Introduction
Mesenchymal stem cells (MSCs) present an advantageous
treatment option where tissue regeneration is required, in
comparison to traditional treatment modalities available in
medicine and dentistry. Autografts procedures have well
known disadvantages, such as additional surgery to remove
tissue from the patient’s own body [1]. Besides the amount
of tissue available may be modest, autograft harvesting is
associated with increased patient pain and high risk of
donor site morbidity [1]. In contrast, studies have con-
firmed that MSC-based tissue regeneration strategies offer
advantages including the avoidance of donor-site harvest-
ing and associated morbidity, high-quality regeneration of
damaged tissues, and low risk of disease transmission or
autoimmune rejection [2–4]. MSCs are multipotent cells
that are capable of differentiation into multiple lineages
depending on the nature of the environmental signals that
they receive. It is well known that MSCs can be identified
in a wide range of postnatal tissues, including the dental
and orofacial tissues [5–10]. Our previous studies and
others have shown that dental MSCs are proliferative
postnatal stem cells capable of differentiating into odon-
togenic, adipogenic, and osteogenic tissues [11–16]. Fur-
thermore, it has been reported that these MSCs might have
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superior proliferation and differentiation capacities com-
pared to bone marrow mesenchymal stem cells
(hBMMSCs), which are the current gold standard for MSC
therapy [5, 7, 11, 17]. Therefore, in combination with an
appropriate scaffold, dental MSCs might be considered
promising candidates for applications in regenerative
medicine and dentistry. Among the different types of dental
MSCs that have been identified so far, dental pulp stem
cells (DPSCs) are of special interest as they are readily
accessible in the oral environment, and also can be readily
found in discarded tissue samples. Several studies have
reported the multilineage differentiation capacity of these
stem cells in vitro and in vivo, confirming their regen-
erative capacities are suitable for applications in medicine
and dentistry [18–22].
It is well known that the cell delivery vehicle plays an
important role in the in vivo performance of MSCs and
strongly contributes to the success of the regenerative ther-
apy. Several studies have reported that providing a suitable
microenvironment for MSC proliferation and differentiation
in response to exogenous stimuli and growth factors is a
critical step towards clinical applications in regenerative
medicine [23]. Several types of scaffolds have been used to
support growth and differentiation of progenitor cells for
tissue regeneration, such as natural and synthetic polymers
[19, 21, 22]. Hydrogels are of specific importance as they
enable noninvasive surgical procedures using stem cell
therapy principles. In addition, synthetic hydrogel materials
that mimic natural stem cell microenvironments may be
powerful tools to control stem cell functions [24].
Pluronic F-127 (poloxamer 407) is a synthetic hydro-
gel made of amphiphilic copolymers consisting of units of
ethylene oxide (PEO) and polypropylene oxide (PPO). It is
injectable and has a reversible mechanism of gelation [25].
Moreover, Pluronic F-127 hydrogel has favorable proper-
ties such as non-toxicity, biocompatibility, and
biodegradability. A unique characteristic of Pluronic F-127
is its thermosensitivity, which enables it to hold encapsu-
lated cells in its structure and favors initial cell adhesion
inside the defect site [26, 27]. Additionally, it has been
shown that Pluronic F-127 enhances cell attachment and
collagen formation, leading to improved levels of angio-
genesis [28, 29]. Therefore, it has been reported that this
type of hydrogel biomaterial may be a promising candidate
for encapsulating MSCs to promote the regeneration of
poorly vascularized tissues, such as cartilage, tendons,
epithelial tissues or even adipose and bony tissues [26, 30–
33]. Brunet-Maheu et al. [31] have shown that Pluronic
F-127 has an optimized cell distribution in the liquid state
with easy manipulation in its solid state. Moreover, the
FDA has approved it for use in humans. Pluronic F-127 has
been widely used in drug delivery, controlled release, and
MSC encapsulation applications [34]. The thermosensitive
properties of Pluronic F-127 make it an attractive bioma-
terial for regenerative applications in dentistry or medicine.
However, a literature search revealed no reports assessing
the application of dental MSCs (e.g., DPSCs) encapsulated
in Pluronic F-127 for tissue engineering purposes. There-
fore, in the present study, we aimed to demonstrate the
osteogenic and adipogenic differentiation capacity of
DPSCs and hBMMSCs in a 3D in vitro environment using
Pluronic F-127 hydrogel scaffold as a potential MSC car-
rier for tissue regeneration/repair of craniofacial tissues.
This approach was designed to optimize tissue regeneration
for potential applications in the repair of soft and hard
tissues. Considering the fact that DPSCs can often be ob-
tained as discarded biological samples or can be easily
harvested from the oral cavity, this MSC source could be
ideal for stem cell banking purposes provided DPSCs show
promise in MSC-based tissue regeneration.
2 Materials and methods
2.1 Progenitor cell isolation and culture
Teeth were obtained from twenty healthy male patients
(18–25 years old) undergoing third molar extractions with
IRB approval from the University of Southern California.
Only subjects without any history of periodontal disease
were included in this study. Human DPSCs were isolated
and cultured according to previously published procedures
[5]. Briefly, teeth were then cracked opened in the laminar
flow hood and the dental pulp tissue was minced and di-
gested in a solution of 4 mg/ml dispase and 3 mg/ml type I
collagenase for 30–60 min at 37 C. Single cells suspen-
sions were obtained by passing cells through a 70 lm cell
strainer. Human bone marrow mesenchymal stem cells
(hBMMSCs) used as controls were purchased from Poetic
Technologies (Gaithersburg, MD, USA). DPSCs and
hBMMSCs were cultured in a-MEM (Invitrogen, Grand
Island, NY) supplemented with 15 % Fetal Bovine Serum
(FBS) (Invitrogen, San Diego, CA, USA), 100 units/ml
penicillin (Invitrogen) and 100 lg/ml streptomycin (Invit-
rogen). Cells were incubated at 37 C in a humid atmo-
sphere containing 5 % CO2. In all the experiments, passage
four cells were used. For the colony forming unit–fibrob-
lastic (CFU-F) assay, 0.1 9 106 cells were seeded in a
culture dish and cultured for 14 days, then stained with
toluidine blue. A count of more than 50 cells in one colony
was counted as positive on the CFU-F assay.
2.2 Flow cytometric analysis
Approximately 5 9 105 DPSCS or hBMMSCs from pas-
sages two to six were incubated with specific PE- or FITC-
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conjugated mouse monoclonal antibodies for human CD45
(as a non-MSC associated marker), CD146 (as a positive
mesenchymal stem cell marker) (BD Biosciences, San
Jose, CA, USA), or isotype-matched control IgGs (South-
ern Biotechnology Associates, Birmingham, AL, USA) and
subjected to flow cytometric analysis using a Beckman
Coulter flow cytometer and FACScan program (BD
Biosciences).
2.3 Biomaterial fabrication and cell encapsulation
Pluronic F-127 (Sigma Aldrich, St Louis, MO, USA;
poloxamer 407) is liquid at 4 C and semi-solid at 37 C. The
protocol reported by Vashi et al. [35] was followed. Briefly,
Pluronic F-127 was slowly added to complete cell culture
medium (a-minimum essential medium, supplemented with
15 % fetal bovine serum, 2 mM L-glutamine, 100 l/ml
penicillin and 100 lg/ml streptomycin) (all from GIBCO/
Invitrogen, Grand Island, NY, USA) and 100 lM L-ascorbic
acid-2-phosphate (Sigma Aldrich) at the ratio of 1:5 w/v by
stirring on ice for 12 h. Before use in cell cultures, the
polymer solution was filtered using a 0.22 lm pore size
bottle-top filter and kept at 4 C overnight. Hydrogel was
kept on ice when manipulated inside the laminar flow hood.
Next, DPSCs or hBMMSCs were re-suspended in
Pluronic F-127 on ice. A cell-hydrogel mixture containing
1 9 106 cells/ml was used in the experiments. After
seeding, the plates were kept in an incubator at 37 C and
5 % CO2 for 5 min to induce gel formation. Homogeneous
cell encapsulation was confirmed by light microscopy.
Regular culture media was overlaid on each plate and
transferred to an incubator at 37 C in a humid atmosphere
containing 5 % CO2.
2.4 Cell viability
A live/dead assay kit (Invitrogen) was utilized to assess the
viability of the encapsulated stem cells in Pluronic F-127
hydrogel after 1, 3 and 7 days of culturing in regular cul-
ture media. A fluorescence microscope (Olympus IX71;
Olympus, Tokyo, Japan) was used to observe the cells.
Five specimens per group were examined and the numbers
of green (live) and red (dead) cells were counted in each
bead. The percentage of live cells and live cell density were
determined from five independent specimens for each ex-
perimental group using the Image-J software (Version 1.64,
NIH, Bethesda, MD, USA). Additionally, in order to
measure stem cell viability in Pluronic F-127 hydrogel
in vitro, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetra-
zolium bromide (MTT) assay (Invitrogen) was utilized
according to methods in the literature [16]. The MTT ab-
sorbance was obtained at different time intervals (1, 3 and
7 days), and normalized to the absorbance of Pluronic
F-127 hydrogel containing the same type of stem cells
measured at day 1 (N = 4).
2.5 In vitro osteogenic differentiation
To study the osteogenic differentiation capacity of DPSCs
and hBMMSCs encapsulated in Pluronic F-127 hydrogel
in vitro, 1 9 106 DPSCs or hBMMSCs were encapsulated
in the hydrogel and cultured in 6-well plates in osteogenic
culture medium containing a-MEM, 15 % FBS, 10,000 l/
ml penicillin and streptomycin, 2 mM L-glutamine,
0.1 mM ascorbic acid phosphate, 1.8 mM potassium di-
hydrogen phosphate (KH2PO4) (Sigma Aldrich) and dex-
amethasone (10-8 M). The medium was changed twice per
week. MSCs seeded in the Pluronic F-127 in regular cul-
ture media were used as controls.
After 4 weeks of culture under osteogenic induction
conditions, the differentiation of the DPSCs and
hBMMSCs was evaluated using Alizarin red staining.
Briefly, the cultures were washed twice with PBS, fixed for
1 min in 60 % isopropanol, and rehydrated with distilled
water. Samples were stained with Alizarin red solution for
5 min and excess dye was removed by washing twice with
deionized water. Retained Alizarin red was quantified us-
ing NIH ImageJ software by determining the percentage of
stained area out of the total area.
2.6 In vitro adipogenic differentiation
In order to study the adipogenic differentiation capacity of
DPSCs and hBMMSCs encapsulated in Pluronic F-127 hy-
drogel in vitro, 1 9 106 of each type of MSC were encap-
sulated in the hydrogel and cultured in adipogenic induction
medium containing a-MEM, 15 % FBS, 10,000 l/ml peni-
cillin and streptomycin, 2 mM L-glutamine, 0.1 mM ascor-
bic acid phosphate, 0.5 mM hydrocortisone, 10 mg/ml
insulin, 50 mM isobutylmethylxanthin and 6 mM in-
domethacin (Sigma Aldrich). Cells were cultured in this
medium for 4 weeks. MSCs seeded in the Pluronic F-127 in
regular culture media were used as controls.
Following 4 weeks of adipogenic differentiation, the
specimens were stained with Oil Red O (Sigma Aldrich)
according to methods in the literature. The specimens were
stained with Oil Red O solution (in 60 % isopropyl alco-
hol) for 45 min, fixed with 60 % isopropyl alcohol, and
washed. The samples were then analyzed under a light
microscope. Four specimens were tested from each group.
2.7 RNA isolation, reverse transcription and real
time PCR
After 2 weeks of osteogenic or adipogenic differentiation,
RNA was extracted from the encapsulated MSCs using
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Trizol reagent (Invitrogen) according to the manufacturer’s
recommendations. Next, single-stranded cDNA was syn-
thesized with 100 ng total RNA using a Superscript III
cDNA synthesis kit (Invitrogen). The relative production of
each mRNA was determined and normalized to the ex-
pression of the internal housekeeping gene GAPDH
(glyceraldehyde 3-phosphate dehydrogenase). Primer and
probe sequences are described in Table 1.
2.8 Degradation profile and swelling kinetics
characterization
In a thermostatic bath, 500 ll of Pluronic F-127 was in-
cubated in a 1.5 ml micro-tube until gelation. The micro-
tubes were filled with 1 ml of regular culture media and the
amount of weight loss after recovery of the samples was
measured at different time intervals (1 h to 1 week). At
each time interval the samples were centrifuged at
10.000 g for 5 min at room temperature, then specimens
were dried and weighed. Microtubes were then stored at
37 C. The degradation profile was evaluated by measuring
the weight loss (%) at each time interval, as reported pre-
viously [36]. In addition, in order to evaluate the water
content of the Pluronic F-127, freeze-dried specimens were
incubated in PBS (pH 7.4) at 37 C and swelling kinetics of
the hydrogel biomaterials were analyzed for up to 10 h. At
each time interval, the weight of the swollen specimens
was measured after the excess surface solution was re-
moved by filter paper. The swelling ratio (SR) was calcu-
lated according to the following formula:
SR ¼ W0  Wt
W0
where Wt and W0 are the weights of the swollen and dried
specimens, respectively. In addition, the effect of increas-
ing the temperature on the swelling ratio of the hydrogels
was determined between 4 and 37 C.
2.9 Scanning electron microscopy (SEM)
In order to characterize the morphology and structure of
Pluronic F-127 hydrogel, scanning electron microscopy
(SEM) (JEOL 5300, Peabody, MA, USA) was utilized.
Sections of semi-solid hydrogel measuring 3 9 3 9 1 mm
were frozen in liquid nitrogen to obtain mechanically
fractured surfaces [37]. Next, specimens were freeze-dried
for 24 h to keep the microporosities open. Lyophilized
specimens were mounted on metallic stubs and sputter-
coated in gold (30 mA, 30 s, 10-2 vacuum) (SCD 050,
BAL-TEC, Furstentum, Liechtenstein) before visualization
under the microscope.
2.10 Statistical analysis
Quantitative data are expressed as mean ± standard de-
viation (SD). One-way analysis of variance (ANOVA)
followed by Tukey’s post hoc test were used to compare
multiple groups at a significance level of a = 0.05.
3 Results
3.1 Characterization and comparison of DPSCs
versus hBMMSCs
In order to analyze the colony-forming ability of the newly
isolated stem cells, a CFU-F assay was utilized. Our data
confirmed that DPSCs formed significantly higher numbers
of single-colony clusters (CFU-F) than hBMMSCs
(Fig. 1a). In addition, the in vitro growth properties of
DPSCs were analyzed and compared to those of
hBMMSCs (Fig. 1b). Both types of tested stem cells ex-
hibited MSC-like fibroblast CFUs, organized as single
CFUs, and adhered to culture dishes. DPSCs showed sig-
nificantly higher proliferation rates than hBMMSCs
Table 1 Oligonucleotide primers used in RT-PCR analysis
Gene Sequence Product (bp)
Runt-related transcription factor 2 (Runx2) Sense: 50-CAGTTCCCAAGCATTTCATCC-30;
Antisense: 50-TCAATATGGTCGCCAAA CAG-30
289
Osteocalcin (OCN) Sense: 50-CATGAGAGCCCTCACA-30;
Antisense: 50-AGAGCGACACCCTAGAC-30
292
Peroxisome proliferatoractivated receptor-g2 (PPAR g2) Sense: 50-CT CCTATTGACCCAGAAAGC-30;
Antisense: 50-GTAGAGCTGAGTCTTCTCAG-30
351
Lipoprotein lipase (LPL) Sense: 50-ATGGAGAGCAAAGCCCTGCTC-30;
Antisense, 50-GTTAGGTCCAGCTGGATCGAG-30
198
Glyceraldehyde 3-phosphate dehydrogenase (GADPH) Sense: 50-AGCCGCATCTTCTTTTGCGTC-3;
Antisense: 50-TCATATTTGGCAGGTTTTT CT-30
418
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(Fig. 1c). FACS analysis confirmed that human DPSCs
display CD 146 (MSC marker), while not expressing CD
45 (non-MSC lineage marker) (Fig. 1d, e) confirming the
stemness of DPSCs.
3.2 Pluronic F-127 hydrogel maintains DPSC
viability
In the current study we investigated the application of
Pluronic F-127 hydrogel as an injectable thermosensitive
vehicle for DPSCs. As a positive control, hBMMSCs en-
capsulated in alginate were used (Fig. 2a). A live/dead-
staining assay was performed and the results exhibited a
high degree of viability of encapsulated MSCs in Pluronic
F-127 hydrogel after 1 week of in vitro culturing (Fig. 2b).
In this assay, live cells were stained green with calcein-
acetoxymethyl, indicating intracellular esterase activity,
and dead cells were stained red with ethidium homodimer-
1, confirming the loss of plasma membrane integrity.
Quantitatively, no significant difference was observed be-
tween the percentages of live cells in the DPSC and
hBMMSC groups (P [ 0.05) (Fig. 2c).
In order to assess the cytotoxicity and metabolic activity
of MSCs encapsulated in Pluronic F127 hydrogel in vitro,
the MTT assay was utilized. All encapsulated MSCs
showed high metabolic activity and viability after up to
1 week of culturing in regular media (Fig. 2d), confirming
the suitability of Pluronic F-127 hydrogel for encapsulation
of DPSCs as well as hBMMSCs.
3.3 Osteogenic and adipogenic differentiation
of DPSCs in vitro
For tissue engineering applications, it is necessary to ana-
lyze and verify the multilineage differentiation potential of
encapsulated DPSCs in vitro. DPSCs after passage 4 were
encapsulated in Pluronic F-127 hydrogel and the culture
medium was changed either to osteogenic or adipogenic
differentiation media. After 4 weeks of culturing in the
osteogenic media, DPSCs and hBMMSCs showed positive
Alizarin red staining (Fig. 3a). As expected, DPSCs ex-
hibited significantly greater mineralized area in comparison
to hBMMSCs (P \ 0.05) (Fig. 3b), confirming the superior
osteogenic potential of DPSCs. Moreover, osteogenesis-
Fig. 1 Characterization of stem cells used in the current study:
a generation of colony-forming units in cultures containing either
dental pulp stem cells (DPSCs) or human bone marrow mesenchymal
stem cells (hBMMSCs) at a low density after 10 days (P val-
ue = 0.032). b Morphological characteristics of hBMMSCs and
DPSCs after 72 h of culturing, showing superior growth properties of
DPSCs in comparison to hBMMSCs c Percentual increase in the cell
number after 1, 3, 5 and 7 days, confirming the morphological
findings. d Flow cytometric analysis demonstrating the expression of
cell surface markers on DPSCs and hBMMSCs (passage 4).
e Quantification of the percentage of cells expressing specific stem
cell markers. The results are representative of at least five indepen-
dent experiments from passage four. *P \ 0.05, **P \ 0.01,
***P \ 0.001, NS not significant
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related genes such as Runt-related transcription factor 2
(Runx2) and Osteocalcin (OCN) were highly expressed in
both lineages after the induction period (Fig. 3e).
Results of the Oil Red O staining showed that both
DPSCs and hBMMSCs within the hydrogel were inten-
sively stained (Fig. 3c). Lipid droplets were observed to be
clustered or randomly distributed for both cell lineages. No
significant difference in the amount of adipogenic tissue
was observed between DPSCs and hBMMSCs (P [ 0.05)
(Fig. 3d). The adipogenesis-related genes including Per-
oxisome proliferators activated receptor c2 (PPAR c2) and
lipoprotein lipase (LPL) were highly expressed for both
cell lineages (Fig. 3e).
3.4 Degradation profile, swelling kinetics,
and morphological characterization
The results of the degradation profile characterization
showed that Pluronic F-127 hydrogel degraded rapidly.
After 1 week of culturing, the hydrogel was fragmented
into many small pieces. Pluronic F-127 hydrogel lost
more than 85 % of its initial weight after 2 weeks of
incubation in regular culture media (Fig. 4a). The swel-
ling kinetics of Pluronic F-127 hydrogel as a function of
time is plotted in Fig. 4b. The results showed that the
examined hydrogel swelled rapidly in PBS and reached
equilibrium within the first 5 h of incubation. Moreover,
as presented in Fig. 4c, a decrease in the swelling ratio of
the hydrogel was observed at elevated temperatures. This
phenomenon is attributed to the thermo-sensitive proper-
ties of the hydrogel.
Figure 5 shows SEM photographs of cross-sectional
morphology of Pluronic F-127 hydrogel, demonstrating
dense tubular and reticular network morphology with well
interconnected pores within the matrix of the hydrogel.
These morphological characteristics contribute to its high
permeability and solubility, consistent with its high
degradability in the tested conditions.
Fig. 2 Development of stem cell delivery vehicle based on Pluronic
F-127 hydrogel maintaining high stem cell viability: a microscopic
images of cells (DPSCs) encapsulated in Pluronic F-127 hydrogel
after 1 and 3 days of culturing in regular culture media. b Live/dead
staining of the stem cells after 1 week of culturing (scale
bar = 200 mm). c Percentages of viable encapsulated stem cells in
Pluronic F-127 hydrogel. d 3-(4,5-Di- methylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay of metabolic activity of
cells showing no significant difference between the two stem cell
groups at each time interval. NS not significant
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4 Discussion
It has been shown that the cell delivery material plays a
vital role in the success of MSC therapies in regenerative
dentistry and medicine. In the current study, we investi-
gated an injectable and biodegradable thermosensitive
hydrogel as a 3D dental MSC delivery vehicle for potential
application in tissue engineering [38–40]. We demon-
strated that this system supported the viability, metabolic
activity and osteogenic and adipogenic differentiation ca-
pacity of encapsulated DPSCs in vitro.
This is the first study to investigate Pluronic F-127
thermosensitive hydrogel encapsulating human dental
MSCs for potential applications in tissue engineering.
Here, we reported based on in vitro studies that Pluronic
F-127 hydrogel appears to be suitable for encapsulation of
DPSCs. Our data confirmed that both DPSCs and
hBMMSCs favorably adhered and proliferated within the
biomaterial and also differentiated into osteogenic or adi-
pogenic tissues in vitro. Our results agree with previous
studies available in literature reporting favorable cell
response and growth upon encapsulation in Pluronic F-127
[31, 35]. Additionally, the current study confirmed that
DPSCs have superior growth properties compared to
hBMMSCs, and also showed greater osteogenic differen-
tiation capacity. Furthermore, in comparison to
hBMMSCs, DPSCs showed higher cell viability in the first
days after encapsulation, which might be attributed to less
sensitivity of DPSCs (in comparison to hBMMSCs) to the
components of the Pluronic F-127 hydrogel or the tem-
perature changes during the gelation of the biomaterial.
Microscopic evaluation of the encapsulated stem cells
showed that cell clustering within the biomaterial happened
within the first few days of culturing. Additionally, during
osteogenic and adipogenic differentiation, aggregation re-
sulted in the formation of macroscopic mineralized and
adipose tissues of several microns in diameter. The os-
teogenic and adipogenic differentiation capacities of the
DPSCs as well as hBMMSCs encapsulated in F-127 hy-
drogel were evaluated in vitro. Our histochemical and PCR
analysis confirmed that both of the tested stem cells are
promising candidates for bone and adipogenic tissue
Fig. 3 In vitro Osteo- and adipo-differentiation of encapsulated stem
cells. a Alizarin red staining. b Mineralization area fraction was
significantly higher for DPSCs in comparison to hBMMSCs. c Oil Red
O staining. d No significant difference was observed in the amounts of
adipogenesis of DPSCs and hBMMSCs. e PCR analysis of osteogenic
and adipogenic gene expression after 2 weeks of differentiation.
GAPDH (housekeeping) gene expression was used as the control.
*P \ 0.05, ***P \ 0.001, NS not significant (Color figure online)
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regeneration. These data correlate well with previous re-
ports, which found that Pluronic F-127 provided a suitable
environment for MSCs to differentiate into osteogenic and
adipogenic tissues [4, 27, 32, 35, 41]. The data obtained
here are specifically important for DPSCs as they are
readily accessible in the oral environment and can be
readily found in discarded tissue samples as well. These
unique characteristics make DPSCs promising candidates
for tissue engineering applications.
Several studies have shown that adding Pluronic F-127
to differentiation media significantly increased alkaline
phosphatase levels during the osteogenic differentiation of
human tooth germ cells [42, 43]. Other studies also
corroborate with our results showing that Pluronic F-127
facilitated MSC growth and differentiation into osteoblasts
on their interpore granules [26]. Additionally, the asso-
ciation of Pluronic F-127, PGE2 and platelet-rich plasma is
reported to support osteoblast phenotype maintenance with
minimal effects on osteoblast viability.
SEM analysis confirmed that Pluronic F-127 had a dense
well-oriented tubular appearance and reticular networks.
These morphological features are of utmost importance as
the oriented channel pores are desirable for providing nu-
trients and oxygen to the encapsulated cells [37]. More-
over, the degree of crosslinking and swelling of the
hydrogel produces morphologies that can increase or
Fig. 4 Characterization of the
degradation behavior of
Pluronic F-127 hydrogel.
a Degradation profile of
Pluronic F-127 hydrogel in PBS
(pH 7.4) at 37 C. b Swelling
behavior of the hydrogel as a
function of time. c Swelling
ratios of Pluronic F-127
hydrogel in PBS buffer (pH 7.4)
at different temperatures
Fig. 5 Morphological characterization of Pluronic F-127 hydrogel. SEM images of Pluronic F-127 hydrogel at a low and b high magnification.
The images show the morphology of the hydrogel, confirming a porous structure
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decrease the rate of diffusion and permeation of biomate-
rials [44]. In this way, tubular morphologies appear to lead
to higher rates of diffusion and permeability of drugs than
spheroidal morphologies [37]. Furthermore, a very fast
degradation profile was observed for Pluronic F-127.
Within the first week of immersion in PBS solution, the
material lost more than 85 % of its initial weight. This
attribute, in addition to the thermosensitivity of this bio-
material, makes Pluronic F-127 a promising candidate for
fast release of stem cells and other sensitive bioactive
molecules in vivo [45]. However, it has to be mentioned
that fast degradation might be disadvantageous for some
tissue engineering applications where a longer-lasting
material is advantageous. Studies have confirmed that
slower degradation can be achieved by mixing Pluronic
F-127 with different additives (e.g. polymers [46–48] or
hydroxyapatite [27]). Modifications such as UV curing
would make this hydrogel even more versatile for clinical
applications [4]. These modifications may benefit the pur-
pose of a specific graft, such as enhanced mechanical
properties and greater drug sustained release [46–48].
Although the presence of body fluids reduces the hy-
drogel concentration, resulting in rather fast disintegration
of the gel in vivo [49], this property might be of importance
for regenerating/repairing avascular or poorly vascularized
tissues, such as cartilage or dense connective tissues (ten-
dons, ligaments). The lack of microvasculature may retard
the degradability of the biomaterial, but not as much as it
impairs the tissue neogenesis due to the persistence of non-
degradable materials in the defect site [4, 27, 30, 32, 41].
The thermo-responsive properties of these hydrogels makes
them attractive biomaterials for encapsulation and delivery
of cells and other sensitive bioactive molecules from the
lab to the warmer environment of the oral cavity and the
rest of the human body.
Further in vivo studies should be conducted to investi-
gate the feasibility of Pluronic F-127 as a cell delivery
scaffold for tissue engineering purposes. In the future, we
plan to use this material in an animal model to study the
ability of encapsulated DPSCs and other dental-derived
MSCs to differentiate upon implantation in vivo. However,
prior to undertaking this in vivo study, it is desirable to
optimize the degradability and osteoconductivity of the
biomaterial further. The results of these endeavors will be
reported in due course.
5 Conclusion
In the current study, dental pulp stem cells were encapsu-
lated in a 3-D thermosensitive biodegradable, and injectable
hydrogel, Pluronic F-127. This material is a promising and
non-toxic scaffold for encapsulation of DPSCs, yielding
high stem cell viability and proliferation. The findings of
this in vitro study demonstrated for the first time that im-
mobilization of DPSCs in Pluronic F-127 hydrogel provides
a promising strategy for tissue engineering. Further in vivo
studies should be conducted to investigate the feasibility of
Pluronic F-127 as a cell delivery scaffold for tissue engi-
neering purposes, and specifically, for oral applications.
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